PMC4558292_01
CT scan Head without Contrast.
JCHIMP-5-27540-g001.jpg
PMC4558292_01_JCHIMP-5-27540-g001.jpg
F0001
Head CT scan (Fig. 1) showed subarachnoid hemorrhage and possible parenchymal hemorrhage in the left frontal lobe without soft tissue or bony lesions.
MRI Brain without contrast.
JCHIMP-5-27540-g002.jpg
PMC4558292_01_JCHIMP-5-27540-g002.jpg
F0002
Head MRI (Fig. 2) showed focal Fluid-attenuated inversion recovery (FLAIR) hyper-intense signal, also consistent with subarachnoid hemorrhage.
MRA Brain.
JCHIMP-5-27540-g003.jpg
PMC4558292_01_JCHIMP-5-27540-g003.jpg
F0003
The MRA brain (Fig. 3) showed normal vasculature and the cause of intracranial bleeding was attributed to SC use.
Troponin trend.
JCHIMP-5-27540-g004.jpg
PMC4558292_01_JCHIMP-5-27540-g004.jpg
F0004
Serial troponin-I levels trended upward to a peak of 7.32 ng/mL (Fig. 4), and repeat EKG showed STEMI (Fig. 5) in leads aVL and I.
CPK trend.
JCHIMP-5-27540-g006.jpg
PMC4558292_01_JCHIMP-5-27540-g006.jpg
F0006
The creatine phosphokinase (CPK) level continued to trend upward, reaching a peak of 301,901 U/L over 2 weeks (Fig. 6).